# Single or Repeat Dose of G03-52-01 in Adult Subjects

> **NCT05348993** · PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 622 (actual)

## Conditions studied

- Healthy
- Botulinum Toxin

## Interventions

- **DRUG:** G03-52-01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05348993
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-15
- **Primary completion:** 2025-02-18
- **Final completion:** 2025-02-18
- **Target enrollment:** 622 (ACTUAL)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05348993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05348993, "Single or Repeat Dose of G03-52-01 in Adult Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05348993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*